Skip to contentS
Skye Bioscience, Inc.
S
SKYESkye Bioscience, Inc. Released Nov 12, 2015, after the close
10-Q filed Nov 12, 2015, 43 days after period end · 0001640334-15-000301
Q3 2015 · 10-Q
Revenue—
Net Income-$1.18M-$1.18MN/M vs Q3 2014N/M vs Q2 2015 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
-$0.07-$0.07
N/M vs Q2 2015
Operating Income-$896,292N/M Operating Cash Flowderived-$1,294,903N/M Filing lag
ended Sep 30, 2015 · filed Nov 12, 2015 · 43 d after period end